227 related articles for article (PubMed ID: 1020762)
1. Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.
Case DB; Wallace JM; Keim HJ; Sealey JE; Laragh JH
Am J Med; 1976 May; 60(6):825-36. PubMed ID: 1020762
[TBL] [Abstract][Full Text] [Related]
2. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
[TBL] [Abstract][Full Text] [Related]
3. Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.
Anderson GH; Streeten DH; Dalakos TG
Circ Res; 1977 Mar; 40(3):243-50. PubMed ID: 837471
[TBL] [Abstract][Full Text] [Related]
4. The immediate pressor response to saralasin in man: a test of angiotensin II receptor vacancy.
Wallace JM; Case DB; Laragh JH; Keim HJ; Drayer JI; Sealey JE
Circ Res; 1979 Jan; 44(1):38-44. PubMed ID: 214254
[TBL] [Abstract][Full Text] [Related]
5. Pressor response to saralasin (1-sar-8-ala-angiotensin II) bolus injection in hypertensive patients.
Waks UA; Maxwell MH; Marks L; Zawada ET; Kaufman JJ
Circulation; 1978 Jun; 57(6):1165-70. PubMed ID: 639240
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
Brunner HR; Gavras H; Ribeiro AB; Posternak L
Prog Biochem Pharmacol; 1976; 12():145-62. PubMed ID: 1019161
[TBL] [Abstract][Full Text] [Related]
7. The immediate pressor response to saralasin: a measure of the degree of angiotensin II vascular receptor vacancy.
Wallace JM; Case DB; Laragh JH; Sealey JE; Keim HJ; Drayer JI
Trans Assoc Am Physicians; 1977; 90():300-12. PubMed ID: 205983
[TBL] [Abstract][Full Text] [Related]
8. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
[TBL] [Abstract][Full Text] [Related]
9. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
Laragh JH; Case DB; Wallace JM; Keim H
Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
[TBL] [Abstract][Full Text] [Related]
10. The immediate pressor effect of saralasin in man.
Carey RM; Vaughan ED; Ackerly JA; Peach MJ; Ayers CR
J Clin Endocrinol Metab; 1978 Jan; 46(1):36-43. PubMed ID: 752023
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II blockade in normal subjects and essential hypertensive patients.
MacGregor GA; Dawes PM
Clin Sci Mol Med Suppl; 1976 Dec; 3():193s-196s. PubMed ID: 1071606
[TBL] [Abstract][Full Text] [Related]
12. Effects of the angiotensin II antagonist 1-sar-8-ala-angiotensin II in hypertension in man.
Fagard R; Amery A; Lijnen P; Reybrouck T
Eur J Clin Invest; 1977 Dec; 7(6):473-9. PubMed ID: 415868
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II blockade in patients with essential hypertension.
MacGregor GA; Dawes PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):53-4. PubMed ID: 1071404
[TBL] [Abstract][Full Text] [Related]
14. Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
Marks LS; Maxwell MH; Kaufman JJ
Ann Intern Med; 1977 Aug; 87(2):176-82. PubMed ID: 889198
[TBL] [Abstract][Full Text] [Related]
15. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
Marks LS; Maxwell MH; Kaufman JJ
Lancet; 1975 Oct; 2(7939):784-7. PubMed ID: 78152
[TBL] [Abstract][Full Text] [Related]
16. Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients.
Fagard R; Amery A; Lijnen P; Reybrouck T
Eur J Clin Pharmacol; 1977 Aug; 12(1):1-5. PubMed ID: 902672
[TBL] [Abstract][Full Text] [Related]
17. Plasma catecholamines and the pressor response to Sar1-Ala8-angiotensin II in man.
McGrath BP; Ledingham JG; Benedict CR
Clin Sci Mol Med; 1977 Oct; 53(4):341-8. PubMed ID: 913058
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II, plasma renin and sodium depletion as determinants of blood pressure response to saralasin in essential hypertension.
Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
Circulation; 1980 May; 61(5):920-4. PubMed ID: 6988103
[TBL] [Abstract][Full Text] [Related]
19. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
Fagard R; Lijnen P; Amery A; Reybrouck T
Contrib Nephrol; 1978; 11():175-8. PubMed ID: 699588
[TBL] [Abstract][Full Text] [Related]
20. Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.
Case DB; Wallace JM; Keim HJ; Weber MA; Sealey JE; Laragh JH
N Engl J Med; 1977 Mar; 296(12):641-6. PubMed ID: 190537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
